ArticleJournal of family & child health2025
Cost-effectiveness of vaccinating children at school - A commentary.
Article in Journal of family & child health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Barriers to vaccination can significantly impact the uptake of influenza vaccines among school-aged children. Offering influenza vaccination within schools could reduce these barriers and promote higher vaccination rates. This commentary critically evaluates an economic evaluation comparing the cost-effectiveness of school-located influenza vaccination (SLIV) programs for elementary and secondary school students against the standard of care, i.e. vaccination in primary care settings. The economic evaluation suggested that SLIV could be cost-effective, particularly when considering indirect cost savings and spillover effects. However, the commentary highlights an insufficient explanation of the underlying mechanisms of spillover effects in improving cost-effectiveness, and a lack of discussion of similar programs aimed at boosting vaccination rates. Future research should investigate population preferences, examining why parents and children opt for SLIV or end up taking practice-based vaccination as a spillover effect of the SLIV program. The role played by heterogeneity, exploring factors such as gender, ethnicity, income, and other socioeconomic characteristics should also be investigated to better understand the program's impact on different population groups.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.